Simon P, Hémet C, Ramassamy C, Costentin J
Unité de Neuropsychopharmacologie expérimentale, Faculté de Médecine et Pharmacie de Rouen, Saint Etienne, France.
Eur Neuropsychopharmacol. 1995 Dec;5(4):509-14. doi: 10.1016/0924-977x(95)00041-m.
Previously established dose-response curves indicated that modafinil 20-40 mg/kg i.p. elicited in mice an obvious stimulation of locomotor activity roughly similar to that induced by (+)amphetamine 2-4 mg/kg. The effects of various agents modifying dopamine transmission were compared on the locomotor response to both drugs. The preferential D2 dopamine receptor antagonist haloperidol 37.5-150 micrograms/kg i.p. suppressed the stimulant effect of (+)amphetamine in a dose dependent manner, but not that of modafinil. The D1 dopamine receptor antagonist SCH 23390 (7.5-30 micrograms/kg s.c.) reversed the (+)amphetamine but not the modafinil induced hyperactivity. The tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (200 mg/kg) suppressed the hyperactivity induced by 4 mg/kg dexamphetamine but not that induced by 20 mg/kg modafinil. Associating L-DOPA 150 mg/kg and benserazide 37.5 mg/kg with (+)amphetamine 2 mg/kg resulted in stereotyped climbing behavior, that was not observed with modafinil 10-80 mg/kg. The profound akinesia induced by reserpine (4 mg/kg s.c.; 5 h before testing) was reversed by (+)amphetamine 2 mg/kg but not by modafinil 40 mg/kg. Finally, on synaptosomes prepared from mouse striata preloaded with [3H]dopamine, modafinil 10(-5) M did not increase the spontaneous [3H]dopamine release whereas (+)amphetamine, at the same concentration, doubled it. From all these differences between the two drugs, it is concluded that the mechanism underlying the modafinil induced stimulant locomotor effect differs completely from that of (+)amphetamine.
先前建立的剂量反应曲线表明,腹腔注射20 - 40毫克/千克的莫达非尼能明显刺激小鼠的运动活性,其程度大致与腹腔注射2 - 4毫克/千克的(+)苯丙胺所诱导的相似。比较了各种影响多巴胺传递的药物对这两种药物所致运动反应的作用。腹腔注射37.5 - 150微克/千克的选择性D2多巴胺受体拮抗剂氟哌啶醇以剂量依赖方式抑制(+)苯丙胺的兴奋作用,但不抑制莫达非尼的作用。D1多巴胺受体拮抗剂SCH 23390(皮下注射7.5 - 30微克/千克)能逆转(+)苯丙胺所致的多动,但不能逆转莫达非尼所致的多动。酪氨酸羟化酶抑制剂α-甲基-对酪氨酸(200毫克/千克)抑制4毫克/千克右旋苯丙胺所致的多动,但不抑制20毫克/千克莫达非尼所致的多动。将150毫克/千克的左旋多巴和37.5毫克/千克的苄丝肼与2毫克/千克的(+)苯丙胺联合使用会导致刻板的攀爬行为,而10 - 80毫克/千克的莫达非尼则不会出现这种情况。利血平(皮下注射4毫克/千克;测试前5小时)所致的严重运动不能可被2毫克/千克的(+)苯丙胺逆转,但不能被40毫克/千克的莫达非尼逆转。最后,在预先加载了[3H]多巴胺的小鼠纹状体制备的突触体上,10(-5)M的莫达非尼不会增加[3H]多巴胺的自发释放,而相同浓度的(+)苯丙胺则使其增加一倍。从这两种药物的所有这些差异可以得出结论,莫达非尼诱导的兴奋运动效应的潜在机制与(+)苯丙胺完全不同。